BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32039937)

  • 1. Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.
    Chen Q; Wang M; Xu Z; Wang M; Jin S; Tian S; Xiao S
    Int J Gynecol Pathol; 2020 Mar; 39(2):136-140. PubMed ID: 32039937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.
    Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
    Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
    Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
    Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
    BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].
    Gilly B; Unholzer A; Strobl-Wildemann G; Haas C; Starz H; Welzel J
    Hautarzt; 2013 Apr; 64(4):290-4. PubMed ID: 23229822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muir-Torre syndrome-associated pleomorphic liposarcoma arising in a previous radiation field.
    Yozu M; Symmans P; Dray M; Griffin J; Han C; Ng D; Parry S; Wong K
    Virchows Arch; 2013 Mar; 462(3):355-60. PubMed ID: 23299928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series.
    Cohen PR; Kurzrock R
    Cureus; 2023 Jan; 15(1):e33975. PubMed ID: 36824550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre Syndrome with Novel Mutation in the MSH2 Gene.
    Ustaoglu E; Agirgol S; Aymelek HS; Turhan EI
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):144-147. PubMed ID: 38439724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
    Neelakantan IV; Di Palma S; Smith CE; McCoombe A
    Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of Muir-Torre syndrome among Lynch syndrome families.
    South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
    J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature.
    Lee N; Luthra R; Lopez-Terrada D; Wang WL; Lazar AJ
    J Cutan Pathol; 2013 Aug; 40(8):730-3. PubMed ID: 23672746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.
    Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B
    J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muir-Torre syndrome: rare association with duodenal carcinoma].
    Bacha D; Deschamps L; Sauvanet A; Couvelard A
    Ann Pathol; 2009 Dec; 29(6):495-8. PubMed ID: 20005439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunohistochemistry in the Muir-Torre Syndrome.
    Oliveira CM; Campos JG; Maia MR; Lobo LE; Valle FF
    An Bras Dermatol; 2015; 90(3 Suppl 1):168-70. PubMed ID: 26312706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Female patient with Muir-Torre syndrome].
    Negraszus N; Jöhrens K; Bertelmann E
    Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muir-Torre syndrome].
    Kudibal MT; Venzo A
    Ugeskr Laeger; 2018 Jul; 180(27):. PubMed ID: 29984696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.